Roma Patel

Dr. Roma Patel

Neuroscience, Albert Einstein College of Medicine, Bronx, New York, USA
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2022 in Biochimie
Verified
Journal Article
Closed access
Roma PatelRoma Patel
Roma Patel
NPNishant Parmar
Nishant Parmar
SPSayantani Pramanik Palit
Sayantani Pramanik Palit
NRNirali Rathwa
Nirali Rathwa
ARA.V. Ramachandran
A.V. Ramachandran
RBRasheedunnisa Begum
Rasheedunnisa Begum

1 July 2018 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
Roma PatelRoma Patel
Roma Patel
NRNirali Rathwa
Nirali Rathwa
SPSayantani Pramanik Palit
Sayantani Pramanik Palit
ARA.V. Ramachandran
A.V. Ramachandran
RBRasheedunnisa Begum
Rasheedunnisa Begum

19 February 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SPSayantani Pramanik Palit
Sayantani Pramanik Palit
Roma PatelRoma Patel
Roma Patel
SJShahnawaz D. Jadeja
Shahnawaz D. Jadeja
NRNirali Rathwa
Nirali Rathwa
AMAnkit Mahajan
Ankit Mahajan
RBRasheedunnisa Begum
Rasheedunnisa Begum
Adiponectin is a prime determinant of the status of insulin resistance. Association studies between adiponectin (ADIPOQ) gene single nucleotide polymorphisms (SNPs) and metabolic diseases have been reported earlier. However, results are ambiguous due to apparent contradictions. Hence, we investigated (1) the association between ADIPOQ SNPs: −11377C/G, +10211T/G, +45T/G and +276G/T for the risk towards type 2 diabetes (T2D) and, (2) genotype-phenotype association of these SNPs with various biochemical parameters in two cohorts. Genomic DNA of diabetic patients and controls from Gujarat and, Jammu and Kashmir (J&K) were genotyped using PCR-RFLP, TaqMan assay and MassArray. Transcript levels of ADIPOQ were assessed in visceral adipose tissue samples, and plasma adiponectin levels were estimated by qPCR and ELISA respectively. Results suggest: (i) reduced HMW adiponectin/total adiponectin ratio in Gujarat patients and its association with +10211T/G and +276G/T, and reduced ADIPOQ transcript levels in T2D, (ii) association of the above SNPs with increased FBG, BMI, TG, TC in Gujarat patients and (iii) increased GGTG haplotype in obese patients of Gujarat population and, (iv) association of −11377C/G with T2D in J&K population. Reduced HMW adiponectin, in the backdrop of obesity and ADIPOQ genetic variants might alter metabolic profile posing risk towards T2D.

17 October 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Roma PatelRoma Patel
Roma Patel
MDMitesh Dwivedi
Mitesh Dwivedi
MMMohmmad Shoab Mansuri
Mohmmad Shoab Mansuri
ANAnsarullah
Ansarullah
NLNaresh C. Laddha
Naresh C. Laddha
RBRasheedunnisa Begum
Rasheedunnisa Begum
Neuropeptide Y (NPY) is known to play a role in the regulation of satiety, energy balance, body weight, and insulin release. Interleukin-1beta (IL1B) has been associated with loss of beta-cell mass in type-II diabetes (TIID). The present study attempts to investigate the association of NPY exon2 +1128 T/C (Leu7Pro; rs16139), NPY promoter -399 T/C (rs16147) and IL1B -511 C/T (rs16944) polymorphisms with TIID and their correlation with plasma lipid levels, BMI, and IL1B transcript levels. PCR-RFLP was used for genotyping these polymorphisms in a case-control study involving 558 TIID patients and 1085 healthy age-matched controls from Gujarat. Linkage disequilibrium and haplotype analysis of the NPY polymorphic sites were performed to assess their association with TIID. IL1B transcript levels in PBMCs were also assessed in 108 controls and 101 patients using real-time PCR. Our results show significant association of both structural and promoter polymorphisms of NPY (p<0.0001 and p<0.0001 respectively) in patients with TIID. However, the IL1B C/T polymorphism did not show any association (p = 0.3797) with TIID patients. Haplotype analysis revealed more frequent association of CC and CT haplotypes (p = 3.34 x 10−5, p = 6.04 x 10−9) in diabetics compared to controls and increased the risk of diabetes by 3.02 and 2.088 respectively. Transcript levels of IL1B were significantly higher (p<0.0001) in patients as compared to controls. Genotype-phenotype correlation of IL1B polymorphism did not show any association with its higher transcript levels. In addition, NPY +1128 T/C polymorphism was found to be associated with increased plasma LDL levels (p = 0.01). The present study provides an evidence for a strong correlation between structural and promoter polymorphisms of NPY gene and upregulation of IL1B transcript levels with susceptibility to TIID and altering the lipid metabolism in Gujarat population.

1 June 2019 in Clinical Nutrition
Verified
Journal Article
Closed access
Roma PatelRoma Patel
Roma Patel
SPSayantani Pramanik Palit
Sayantani Pramanik Palit
NRNirali Rathwa
Nirali Rathwa
ARA.V. Ramachandran
A.V. Ramachandran
RBRasheedunnisa Begum
Rasheedunnisa Begum

1 July 2019 in Cytokine
Verified
Journal Article
Closed access
NRNirali Rathwa
Nirali Rathwa
Roma PatelRoma Patel
Roma Patel
SPSayantani Pramanik Palit
Sayantani Pramanik Palit
SJShahnawaz D. Jadeja
Shahnawaz D. Jadeja
MNMahendra Narwaria
Mahendra Narwaria
RBRasheedunnisa Begum
Rasheedunnisa Begum